Generic name |
finerenone |
|
---|---|---|
Strength |
10 mg, 20 mg |
|
Form |
tablets |
Special Authority criteria |
Approval period |
---|---|
As an adjunct to standard care therapy1 to reduce the risk of end-stage kidney disease and a sustained decrease in estimated glomerular filtration rate (eGFR), and cardiovascular death, non-fatal myocardial infarction, and hospitalization for heart failure in adult patients with both chronic kidney disease (CKD) and type 2 diabetes (T2D) who:
AND
AND
AND
AND
AND
AND
|
Indefinite |